Leveraging Single-Cell Sequencing to Identify Highly Precise T-Cell Engager Targets
Time: 1:15 pm
day: Day 2
Details:
- Developing the ATLAS platform, a curated single-cell RNA sequencing resource that leverages both healthy and tumor-derived datasets to identify highly precise TCE targets
- Leveraging single-cell RNA sequencing to identify highly precise tumor-selective T-cell engager (TCE) targets
- Engineering a best-in-class TCE targeting LY6G6D for colorectal cancer (CRC) based on single-cell insights
